P920: EVALUATION OF EARLY PROGRESSIVE DISEASE (EPD) IN NEWLY DIAGNOSED MYELOMA PATIENTS AND IDENTIFICATION OF PROGNOSTIC FACTORS IN THE ERA OF MODERN THERAPIES. THE GREEK MYELOMA STUDY GROUP EXPERIENCE.

Detalles Bibliográficos
Autores principales: Katodritou, Eirini, Kastritis, Efstathios, Dalampira, Dimitra, Theodorakakou, Fotini, Fotiou, Despina, Delimpasi, Sosana, Spanoudakis, Emmanouil, Ntanasis-Stathopoulos, Ioannis, Papadopoulou, Theodosia, Sevastoudi, Aggeliki, Triantafyllou, Theodora, Daiou, Aikaterini, Pouli, Anastasia, Migkou, Magdalini, Gavriatopoulou, Maria, Verrou, Evgenia, Christine Kyrtsonis, Marie, Dimopoulos, Meletios A., Terpos, Evangelos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Posters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430951/
http://dx.doi.org/10.1097/01.HS9.0000970584.69658.38

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430951/
http://dx.doi.org/10.1097/01.HS9.0000970584.69658.38

Ejemplares similares